Decideum

Health policy and market access consultancy with over 25 years expertise.
Retweets are not necessarily endorsement.

[Decideum @Decideum]

Decideum has joined two other companies to become @NewmarketStrtgy, a new consultancy specialising in #healthcare #innovation. Please follow Newmarket Strategy for similar content & regular updates on UK healthcare and life sciences.

[Newmarket Strategy @NewmarketStrtgy]

Introducing Newmarket Strategy: https://t.co/lYZpIE8Uqt

[NICE @NICEComms]

Have you listened to the latest episode of the NICE Talks podcast on digital health technologies? You can download or stream where ever you listen to your podcasts: https://t.co/JmxCZIOZhk

[Decideum @Decideum]

Jo Churchill MP announced that the UK has secured continuity of supply for Bedrocan #cannabis oils from the Netherlands until at least 1 July. Access was discontinued when the UK ceased to be an EU state, as the Dutch Government does not allow its export.

https://t.co/CIDC7aqDnt

[EU Medicines Agency @EMA_News]

In 2020, EMA recommended 97 #medicines for marketing authorisation. Check out our annual human medicines highlights: https://t.co/yG1yI6lO6a

[Decideum @Decideum]

#NICE has agreed a managed access agreement through the #Cancer Drugs Fund for Tecartus, a CAR-T therapy, so more data can be collected while patients access the treatment. Currently there isn't enough evidence to tell if patients can be cured with it.

https://t.co/F1bSFoajPC

[Decideum @Decideum]

Consultant Chris Melson has written a handy summary and analysis of the UK #raredisease framework, which you can read on the #decideum website.

Read 'UK Rare Diseases Framework: An optimistic vision' here: https://t.co/Xfshdmz0i4

#marketaccess

[Decideum @Decideum]

Insightful @politico article. Whereas the #UK secured early access to #vaccines, Brussels' more cautious approach to the science & protecting its taxpayers from liability might mean the #EU strategy will 'win out' in the long term.

https://t.co/ELBQ6JERof

#marketaccess

[Decideum @Decideum]

Government has updated its response to the Cumberlege Review, committing to establish a #Patient Safety Commissioner, a Safe Medicines in Pregnancy and Breastfeeding Consortium, and increase transparency between HCPs and #pharmaceutical companies.

https://t.co/o8281Ekio2

[Rare Disease UK @rarediseaseuk]

Are you affected by a #RareDisease? The UK Rare Diseases Framework is out now https://t.co/oYb7pXtRrN
@DHSCgovuk

@DHSCmedia
#UKRareDiseasesFramework

[Decideum @Decideum]

Companies can now submit drugs to the Innovative Licensing and Access Pathway & receive guidance from #NICE, #MHRA, the #SMC, #NHSE&I. If working as intended, it should expedite access to innovative medicines & increase the attractiveness of the UK market.
https://t.co/iwzKbgm76j

[Decideum @Decideum]

End-of-year article reflecting on the major developments in the life sciences industry over 2020 - a year of immense struggle, but also reflection & realisation of what can be achieved.

Read 'The Year Nobody Wanted, But The One We Might Have Needed' here: https://t.co/QFWbE2dNQy

[Decideum @Decideum]

NICE’s consultation on the proposed case for change for its methods of health technology evaluation closes today. Read our full response below!

#marketaccess #healtheconomics #NICE #HTA

https://t.co/RXXMPJ3Z3R

[Decideum @Decideum]

@MHRAgovuk has issued guidance on Project Orbis, an international programme that aims to speed up access to promising #cancer treatments.

You can read #Decideum's briefing & analysis here: https://t.co/5Ki6fS5LMs

#mhra #projectorbis #oncology #marketaccess

[Decideum @Decideum]

@raconteur & @thetimes have published a special report into the future of #pharmaceuticals, examining how COVID is building trust in Big #Pharma, rehabilitating psychedelics, #vaccine hesitancy, and more.

You can read the full report here: https://t.co/EGMQ0iRIJP

[Decideum @Decideum]

The @OHENews has published a summary of @NICEComms 's methods consultation, including modifiers, discount rates, uncertainty and the appraisal of innovative technologies.

Read on: https://t.co/ObwgZxQTYy

[Decideum @Decideum]

The Prime Minister has launched a new capital investment fund, the #Medicines and #Diagnostic Manufacturing Transformation Fund, with an initial pot of £20m - it will open up investment opportunities across the UK & improve domestic supply chains.

https://t.co/ceeeuQAzua

[Decideum @Decideum]

Chief Executive of @TheKingsFund , Richard Murray, has written an open letter to the Chancellor outlining why health and care services need the stability of a multi-year funding deal.

https://t.co/T9NTy6r6oQ

#spendingreview #nhs #healthcare

[Decideum @Decideum]

@NHSConfed Chief Exec, Danny Mortimer, has welcomed a reported extra £3bn funding for the #NHS, but warns it is not enough. Without more funding "Government will need to manage expectations and ensure patients understand their care could be disrupted.”

https://t.co/ZM9Sj6B5Tf

[Decideum @Decideum]

Public Health England published a report into antimicrobial resistance for #Antimicrobial Awareness Week (18-24 Nov). Despite a steady decrease in the use of antibiotics, AMR infections have risen by 32% since 2015.

https://t.co/RD2w44tytS

[Decideum @Decideum]

European alliance formed to drive the transformation to value-based, sustainable and people-centred health systems.

#marketaccess #medicines #healtheconomics #medicaldevices

[European Alliance for Value in Health @ValueInHealthEU]

11 associations representing stakeholders across European health systems are delighted to launch today an Alliance for Value in Health! We will collaborate, connect, and create together -> Read our press statement here:

➡️https://t.co/r2ohIn2Kms

#ValueInHealth